Aldosterone

1 Chemistry and biosynthesis

Aldosterone is a steroid hormone in the mineralocorticoid class. It is synthesized in the adrenal cortex from cholesterol through a series of enzymatic steps that produce a molecule specialized for controlling electrolyte balance. Its production is tightly regulated, allowing rapid adjustment of sodium retention and potassium loss according to the body’s needs.

1.1 Steroid structure

Aldosterone has the four-ring core typical of steroid hormones. Its chemical features make it lipophilic enough to cross cell membranes and interact with intracellular receptors. Compared with many other adrenal steroids, it contains structural modifications that confer high mineralocorticoid activity.

1.2 Adrenal origin

The hormone is produced mainly in the zona glomerulosa, the outermost layer of the adrenal cortex. This region is uniquely equipped with the enzymes needed for aldosterone synthesis. Unlike the deeper adrenal zones, it responds strongly to changes in blood potassium and to signals from the renin-angiotensin system.

1.3 Biosynthetic pathway

Aldosterone synthesis begins with cholesterol and proceeds through a sequence of hydroxylation and oxidation reactions. The pathway is organized so that each enzymatic step progressively converts a common steroid precursor into an active mineralocorticoid. The final reactions occur in the mitochondria of glomerulosa cells.

1.3.1 Cholesterol conversion steps

Cholesterol is first transported into steroid-producing cells and converted into pregnenolone. Through intermediate compounds, it is transformed into progesterone and then into 11-deoxycorticosterone. Further modifications lead to corticosterone, which is then converted to aldosterone. Each step narrows the chemical possibilities until the hormone’s final biologically active form is created.

1.3.2 Enzymes involved in synthesis

Aldosterone synthesis depends on several enzymes, especially steroidogenic acute regulatory protein, 3β-hydroxysteroid dehydrogenase, 21-hydroxylase, 11β-hydroxylase, and aldosterone synthase. Aldosterone synthase, also known as CYP11B2, is the key enzyme that catalyzes the final stages of production. Its expression is largely restricted to the zona glomerulosa.

1.4 Secretion and regulation

Aldosterone secretion changes quickly in response to signals that reflect circulatory status and electrolyte concentration. The hormone is released into the bloodstream in amounts that help preserve blood pressure and plasma composition. Regulation is especially sensitive to low effective blood volume and elevated potassium levels.

1.4.1 Renin-angiotensin system

The renin-angiotensin system is the principal regulator of aldosterone secretion. Reduced renal perfusion stimulates renin release, which leads to formation of angiotensin II. Angiotensin II acts on the adrenal cortex to increase aldosterone production. This system links kidney sensing to adrenal hormone output.

1.4.2 Potassium regulation

Rising extracellular potassium directly stimulates zona glomerulosa cells. This effect promotes aldosterone release even when blood volume is unchanged. The response helps restore potassium balance by increasing renal excretion of the ion.

1.4.3 Adrenocorticotropic hormone influence

Adrenocorticotropic hormone has a limited and usually transient effect on aldosterone secretion. It can support steroid production, especially under acute stress, but it is not the main long-term regulator. Its influence is generally smaller than that of angiotensin II or potassium.

2 Physiologic actions

Aldosterone acts primarily to conserve sodium and water while promoting potassium and hydrogen ion excretion. These actions are central to maintaining extracellular fluid volume, electrolyte stability, and acid-base balance. Its effects are most prominent in the kidney but also occur in several other tissues.

2.1 Renal effects

The kidney is the major target organ for aldosterone. In the distal nephron, the hormone alters transport processes that determine the final composition of urine. These changes support retention of sodium and help control the body’s potassium burden.

2.1.1 Sodium reabsorption

Aldosterone increases sodium reabsorption in the distal tubules and collecting ducts. As sodium moves back into the bloodstream, water tends to follow osmotically. This effect contributes to expansion of extracellular fluid volume.

2.1.2 Potassium excretion

The hormone enhances potassium secretion into the tubular fluid. This action occurs mainly in principal cells of the collecting duct. By increasing potassium loss in urine, aldosterone helps prevent hyperkalemia.

2.1.3 Hydrogen ion handling

Aldosterone also stimulates hydrogen ion secretion, particularly by intercalated cells. This supports acid excretion and can contribute to metabolic alkalosis when hormone levels are excessive. The effect is part of its broader role in maintaining electrolyte and acid-base equilibrium.

2.2 Effects on blood volume and pressure

By promoting sodium retention, aldosterone increases circulating volume. Greater volume can raise venous return and cardiac output, which in turn supports arterial pressure. The hormone is therefore an important contributor to long-term blood pressure regulation.

2.3 Extra-renal actions

Although the kidney is the main site of action, aldosterone also influences other epithelial tissues. In these sites, it similarly modifies salt transport and fluid composition. Such effects are smaller in scale but physiologically meaningful.

2.3.1 Cardiovascular effects

Aldosterone can affect blood vessels and the heart indirectly through changes in fluid balance and directly through receptor-mediated actions in cardiovascular tissues. Its broader cardiovascular effects are often discussed in relation to volume load and tissue remodeling. These actions are part of why persistent excess hormone can be harmful.

2.3.2 Effects on sweat and salivary glands

In sweat and salivary glands, aldosterone promotes sodium conservation. This reduces salt loss in secretions, especially during states where preserving body sodium is important. The response is similar in principle to its renal action.

2.3.3 Effects on the colon

The colon responds to aldosterone by increasing sodium absorption and potassium secretion. This helps conserve sodium when dietary intake is low or losses are increased. The effect becomes more relevant in conditions of sodium depletion.

3 Mechanism of action

Aldosterone acts mainly through an intracellular receptor that alters gene expression. Because it is a steroid hormone, it diffuses across cell membranes rather than relying on surface receptors. The resulting changes in transport proteins are responsible for most of its physiologic effects.

3.1 Mineralocorticoid receptor binding

Aldosterone binds the mineralocorticoid receptor in target cells. The hormone-receptor complex then influences transcription of specific genes. This binding is the first step in the molecular pathway leading to altered sodium and potassium transport.

3.2 Genomic effects

The receptor complex acts in the nucleus to change gene expression. It increases production of proteins involved in sodium entry, sodium pumping, and potassium handling. These genomic effects develop over hours and help sustain longer-term responses.

3.3 Cellular transport mechanisms

Aldosterone increases activity of epithelial sodium channels and sodium-potassium ATPase pumps. These transport systems move sodium into the body and potassium into the urine. Additional channels and transporters are also modulated, reinforcing the hormone’s mineralocorticoid action.

3.4 Target tissues

The most important target tissues are the kidney distal nephron, colon, sweat glands, and salivary glands. In each of these locations, aldosterone promotes electrolyte conservation or redistribution. The response depends on receptor presence and local cellular machinery.

4 Regulation of aldosterone levels

Aldosterone levels fluctuate according to circulatory, electrolyte, and hormonal inputs. The body adjusts secretion to preserve internal stability under changing conditions. Regulation is integrated with blood pressure control and renal function.

4.1 Renin-angiotensin-aldosterone system

The renin-angiotensin-aldosterone system is the central feedback network controlling aldosterone release. When blood pressure or renal perfusion falls, renin is released and angiotensin II is generated. This cascade stimulates the adrenal cortex to secrete more aldosterone.

4.2 Electrolyte feedback

Plasma potassium is a direct feedback signal for aldosterone production. High potassium strongly increases secretion, whereas low potassium suppresses it. Sodium status influences the hormone more indirectly, mainly through its effect on the renin-angiotensin system.

4.3 Circadian and postural influences

Aldosterone secretion varies across the day and with body position. Levels are often higher in the morning and may rise when a person stands, reflecting changes in effective arterial volume. These variations are usually modest but physiologically consistent.

4.4 Pathophysiologic triggers

Aldosterone can rise in response to states such as dehydration, reduced effective blood volume, heart failure, or renal artery narrowing. Persistent stimulation may lead to chronic excess secretion. In some disorders, the gland produces the hormone autonomously rather than in response to normal feedback signals.

5 Clinical significance

Abnormal aldosterone production or action can cause major disturbances in blood pressure and electrolyte balance. Both excess and deficiency may produce recognizable clinical syndromes. Evaluation often focuses on identifying the source of dysregulation and its physiologic consequences.

5.1 Hyperaldosteronism

Hyperaldosteronism refers to excessive aldosterone activity. It typically leads to hypertension, low potassium, and metabolic alkalosis, although not every case shows all three findings. The disorder may be primary, arising from the adrenal gland, or secondary, driven by external stimulation.

5.1.1 Primary aldosteronism

Primary aldosteronism results from autonomous aldosterone production by the adrenal cortex. Common causes include adrenal adenoma and bilateral adrenal hyperplasia. The condition is an important cause of potentially treatable hypertension.

5.1.2 Secondary aldosteronism

Secondary aldosteronism occurs when aldosterone rises in response to increased renin and angiotensin II. It can appear in conditions that reduce renal perfusion or effective arterial volume. The adrenal gland is responding appropriately to upstream signals, even though the result may still be excessive.

5.2 Hypoaldosteronism

Hypoaldosteronism is a state of insufficient aldosterone production or response. It may lead to sodium loss, low blood pressure, and elevated potassium. The disorder can result from adrenal damage, enzyme defects, or impaired regulatory pathways.

5.2.1 Adrenal insufficiency

Adrenal insufficiency may reduce aldosterone synthesis if the cortex is significantly impaired. In severe cases, both glucocorticoid and mineralocorticoid functions are affected. Symptoms often reflect salt wasting and reduced circulatory volume.

5.2.2 Congenital enzyme defects

Inherited defects in steroid synthesis can lower aldosterone production. Depending on the missing enzyme, precursor hormones may accumulate while mineralocorticoid output falls. These disorders are often recognized in infancy or childhood because of electrolyte abnormalities.

5.3 Effects on blood pressure and electrolytes

Excess aldosterone tends to raise blood pressure through sodium and water retention. It also lowers serum potassium and may increase renal hydrogen loss. Deficiency produces the opposite pattern, with salt wasting, hypotension, and hyperkalemia.

5.4 Diagnostic testing

Testing for aldosterone disorders often combines hormone measurement with assessment of renin and physiologic response. Interpretation depends on posture, salt intake, medications, and sample timing. Confirmatory studies help distinguish autonomous secretion from compensatory activation.

5.4.1 Plasma aldosterone measurement

Plasma aldosterone concentration provides a direct estimate of hormone output. Values must be interpreted in clinical context because secretion is highly variable. A single measurement is rarely sufficient on its own.

5.4.2 Aldosterone-renin ratio

The aldosterone-renin ratio is widely used to screen for primary aldosteronism. A high ratio suggests disproportionate aldosterone secretion relative to renin activity. It is one of the most important initial tests in suspected cases.

5.4.3 Suppression and stimulation tests

Suppression tests examine whether aldosterone production can be reduced by salt loading or related maneuvers. Stimulation tests may assess whether the hormone responds appropriately to physiologic cues. These studies help separate autonomous production from normal regulatory behavior.

6 Pharmacology and therapeutic relevance

Several drugs target aldosterone action or synthesis. These medications are used in cardiovascular, renal, and endocrine disorders where reducing mineralocorticoid effects is beneficial. Treatment choice depends on the underlying cause and the patient’s electrolyte status.

6.1 Mineralocorticoid receptor antagonists

Mineralocorticoid receptor antagonists block aldosterone from activating its receptor. They reduce sodium retention and lessen potassium loss. Their use is common in conditions associated with excess aldosterone activity.

6.1.1 Spironolactone

Spironolactone is a classic mineralocorticoid receptor antagonist. It also interacts with other steroid receptors to some extent, which can produce endocrine side effects. Despite this, it remains a widely used therapy.

6.1.2 Eplerenone

Eplerenone is a more selective mineralocorticoid receptor antagonist. Its greater receptor specificity reduces some off-target hormonal effects. It is often chosen when a more targeted profile is desired.

6.2 Aldosterone synthesis inhibitors

Some drugs reduce aldosterone production by interfering with steroidogenic enzymes. These agents are less commonly used than receptor blockers. They may be considered when lowering hormone synthesis itself is advantageous.

6.3 Clinical uses of aldosterone-modulating drugs

Aldosterone-modulating drugs are used in hypertension, heart failure, primary aldosteronism, and certain states of fluid retention. They may also help correct hypokalemia caused by excessive mineralocorticoid activity. Their effects can improve both symptoms and biochemical abnormalities.

6.4 Adverse effects and monitoring

Treatment can cause hyperkalemia, particularly in patients with reduced kidney function. Blood pressure, kidney function, and serum electrolytes are commonly monitored during therapy. Some agents may also produce endocrine or gastrointestinal side effects.

7 Related hormones and endocrine context

Aldosterone functions within a broader steroid and peptide hormone network. Its regulation depends on interactions with other adrenal and vascular signals. Understanding these relationships clarifies its role in homeostasis.

7.1 Comparison with cortisol

Cortisol and aldosterone are both adrenal steroid hormones, but they serve different primary purposes. Cortisol is mainly a glucocorticoid involved in metabolism and stress responses, while aldosterone is a mineralocorticoid focused on salt balance. Their structural similarity reflects shared synthetic pathways.

7.2 Relationship to renin and angiotensin II

Renin initiates the pathway that leads to angiotensin II formation, and angiotensin II is a major stimulus for aldosterone release. This relationship forms a tightly coordinated system that links kidney perfusion to adrenal output. Together, these signals help stabilize blood pressure and volume.

7.3 Role within adrenal steroidogenesis

Aldosterone is the terminal product of one branch of adrenal steroidogenesis. Its synthesis depends on enzyme expression that distinguishes the zona glomerulosa from other cortical zones. This specialization allows the adrenal gland to produce hormones with distinct physiologic roles.